Monocyte Chemoattractant Protein-1-2518 G/A Polymorphism, Plasma Levels, and Premature Stable Coronary Artery Disease

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2009 Feb 28

PMID 19247801

Citations 6

Authors

Chen Zhong

Zhang Luzhan

Ma Genshan

Wang Jiahong

Zhang Xiaoli

Qian Qi

Affiliations

Soon will be listed here.

Abstract

Background: We examined the -2518G/A polymorphism of the MCP-1 gene, its plasma levels, and premature stable CAD in a Chinese population.

Methods: The study comprised 132 patients with premature stable CAD (cases) and 153 controls. Genotypes were determined by ligase detection reaction-polymerase chain reaction sequencing and grouping. Plasma MCP-1 level was detected with enzyme-linked immunosorbent assay.

Results: No differences were found between genotype distribution and allele frequencies of MCP-1 gene -2518 G/A polymorphism (AA:18.1%; AG:51.5%; GG:30.3% in cases; AA:16.3%; AG:52.9%; GG:30.7% in controls; P = 0.918). The G allele prevalence was 0.561 in cases and 0.572 in controls (P = 0.786). No significant difference was found in plasma MCP-1 level between cases and controls [(47.50 +/- 26.65) vs. (41.05 +/- 15.71) pg/ml, P = 0.272)] or among the 3 genotypes [AA, (43.49 +/- 10.50) pg/ml; AG, (46.09 +/- 25.08) pg/ml; GG, (40.03 +/- 18.13) pg/ml; P = 0.381]. Logistic regression analysis confirmed the lack of association between MCP-1-2518 G/A single nucleotide polymorphism and premature stable CAD after adjustment for confounding parameters.

Conclusions: The MCP-1-2518 G/A single nucleotide polymorphism does not affect plasma levels of MCP-1 or susceptibility to premature stable CAD in a Chinese population.

Citing Articles

rs1024611 Polymorphism, MCP-1 Concentrations, and Premature Coronary Artery Disease: Results of the Genetics of Atherosclerotic Disease (GEA) Mexican Study.

Posadas-Sanchez R, Velazquez-Sanchez F, Reyes-Barrera J, Cardoso-Saldana G, Velazquez-Argueta F, Antonio-Villa N Biomedicines. 2024; 12(6).

PMID: 38927499 PMC: 11201762. DOI: 10.3390/biomedicines12061292.

Molecular mechanisms in microRNA-mediated TRB3 gene and hypertension left ventricular hypertrophy.

Zeng J, Lei J, Wei Y, Zheng Z, Zhang W, Fu Y Exp Ther Med. 2017; 13(5):1907-1911.

PMID: 28565784 PMC: 5443244. DOI: 10.3892/etm.2017.4220.

Association of monocyte chemoattractant protein-1-2518A/G polymorphism and risk of coronary artery disease among the Chinese population: a meta-analysis.

Zuo S, Wang H, Wang B Int J Clin Exp Med. 2015; 8(9):15182-9.

PMID: 26629002 PMC: 4658891.

The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals.

Cai G, Zhang B, Weng W, Shi G, Huang Z Mol Biol Rep. 2014; 42(5):997-1012.

PMID: 25413568 DOI: 10.1007/s11033-014-3836-8.

Thicker Carotid Intima Media Thickness in Children with Monocyte Chemoattractant Protein-1: A-2138T and A-2464G Mutation.

Yueniwati Y, Yurina V, Indra M Neurol Res Int. 2014; 2014:176535.

PMID: 24860665 PMC: 4016921. DOI: 10.1155/2014/176535.

References

Nelken N, Coughlin S, Gordon D, Wilcox J . Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991; 88(4):1121-7. PMC: 295565. DOI: 10.1172/JCI115411. View

Chamorro A, Hallenbeck J . The harms and benefits of inflammatory and immune responses in vascular disease. Stroke. 2006; 37(2):291-3. PMC: 1852506. DOI: 10.1161/01.STR.0000200561.69611.f8. View

Jemaa R, Rojbani H, Kallel A, Ben Ali S, Feki M, Chabrak S . Association between the -2518G/A polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene and myocardial infarction in Tunisian patients. Clin Chim Acta. 2008; 390(1-2):122-5. DOI: 10.1016/j.cca.2008.01.004. View

JIBIKI T, Terai M, Shima M, Ogawa A, Hamada H, Kanazawa M . Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum. 2001; 44(9):2211-2. DOI: 10.1002/1529-0131(200109)44:9<2211::aid-art375>3.0.co;2-a. View

Cermakova Z, Petrkova J, Arakelyan A, Drabek J, Mrazek F, Lukl J . The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population. Int J Immunogenet. 2005; 32(5):315-8. DOI: 10.1111/j.1744-313X.2005.00530.x. View

Cam S, Sekuri C, Sagcan A, Ercan E, Tengiz I, Alioglu E . Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest. 2008; 68(8):801-5. DOI: 10.1080/00365510802287257. View

Iwai N, Kajimoto K, Kokubo Y, Okayama A, Miyazaki S, Nonogi H . Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese. Circ J. 2006; 70(7):805-9. DOI: 10.1253/circj.70.805. View

Hallenbeck J, Hansson G, Becker K . Immunology of ischemic vascular disease: plaque to attack. Trends Immunol. 2005; 26(10):550-6. DOI: 10.1016/j.it.2005.08.007. View

McDermott D, Yang Q, Kathiresan S, Cupples L, Massaro J, Keaney Jr J . CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation. 2005; 112(8):1113-20. DOI: 10.1161/CIRCULATIONAHA.105.543579. View

10.

Hwang S, Cho M, Park B, Kim J, Kim Y, Min D . Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease. Eur J Immunogenet. 2002; 29(5):413-6. DOI: 10.1046/j.1365-2370.2002.00346.x. View

11.

Hojo Y, Ikeda U, Takahashi M, Shimada K . Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis. 2002; 161(2):403-8. DOI: 10.1016/s0021-9150(01)00636-0. View

12.

Rollins B . Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today. 1996; 2(5):198-204. DOI: 10.1016/1357-4310(96)88772-7. View

13.

Favis R, Day J, Gerry N, Phelan C, Narod S, BARANY F . Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol. 2000; 18(5):561-4. DOI: 10.1038/75452. View

14.

McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox D . A common allele on chromosome 9 associated with coronary heart disease. Science. 2007; 316(5830):1488-91. PMC: 2711874. DOI: 10.1126/science.1142447. View

15.

He J, Gu D, Wu X, Reynolds K, Duan X, Yao C . Major causes of death among men and women in China. N Engl J Med. 2005; 353(11):1124-34. DOI: 10.1056/NEJMsa050467. View

16.

Shah S . Gene polymorphisms and susceptibility to coronary artery disease. Pediatr Blood Cancer. 2007; 48(7):738-41. DOI: 10.1002/pbc.21110. View

17.

de Lemos J, Morrow D, Blazing M, Jarolim P, Wiviott S, Sabatine M . Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol. 2007; 50(22):2117-24. DOI: 10.1016/j.jacc.2007.06.057. View

18.

Qian Q, Chen Z, Ma G, Jiang Y, Feng Y, Shen C . Complement factor H Y402H polymorphism, plasma concentration and risk of coronary artery disease. Mol Biol Rep. 2008; 36(6):1257-61. DOI: 10.1007/s11033-008-9306-4. View

19.

Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A . A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007; 316(5830):1491-3. DOI: 10.1126/science.1142842. View

20.

Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, Kondo I . Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res. 2003; 26(9):677-83. DOI: 10.1291/hypres.26.677. View